West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support its customers by delivering over 40 billion components and devices each year.
Company profile
Ticker
WST
Exchange
Website
CEO
Eric Green
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Integra Lifesciences ...
Former names
WEST CO INC
SEC CIK
Corporate docs
Subsidiaries
West Pharmaceutical • Tech Group Europe Limited • Tech Group • TGPR Holdings Limited • WD SG Pte. Ltd. • West Services and Solutions, LLC • West Contract Manufacturing, LLC • West Pharma. Services IL, Ltd. • West Pharmaceutical Products Ireland, Ltd. • West Pharmaceutical Services Australia ...
IRS number
231210010
WST stock data
Analyst ratings and price targets
Latest filings (excl ownership)
SD
Conflict minerals disclosure
25 May 23
8-K
Submission of Matters to a Vote of Security Holders
28 Apr 23
10-Q
2023 Q1
Quarterly report
27 Apr 23
8-K
West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
27 Apr 23
ARS
2022 FY
Annual report to shareholders
15 Mar 23
DEFA14A
Additional proxy soliciting materials
15 Mar 23
DEF 14A
Definitive proxy
15 Mar 23
10-K
2022 FY
Annual report
21 Feb 23
8-K
West Announces Fourth-Quarter and Full-Year 2022 Results
16 Feb 23
10-Q
2022 Q3
Quarterly report
27 Oct 22
Transcripts
WST
Earnings call transcript
2023 Q1
27 Apr 23
WST
Earnings call transcript
2022 Q4
16 Feb 23
WST
Earnings call transcript
2022 Q3
27 Oct 22
WST
Earnings call transcript
2022 Q2
28 Jul 22
WST
Earnings call transcript
2022 Q1
28 Apr 22
WST
Earnings call transcript
2021 Q4
17 Feb 22
WST
Earnings call transcript
2021 Q3
28 Oct 21
WST
Earnings call transcript
2021 Q2
29 Jul 21
WST
Earnings call transcript
2021 Q1
30 Apr 21
WST
Earnings call transcript
2020 Q4
18 Feb 21
Latest ownership filings
4
Charles Witherspoon
31 May 23
4
Chad Winters
31 May 23
4
Eric Mark Green
11 May 23
144
Notice of proposed sale of securities
9 May 23
4
Chad Winters
9 May 23
4
Thomas W Hofmann
2 May 23
4
Silji Abraham
2 May 23
4
Annette F Favorite
2 May 23
144
Notice of proposed sale of securities
1 May 23
4
Stephen H Lockhart
27 Apr 23
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 886.30 mm | 886.30 mm | 886.30 mm | 886.30 mm | 886.30 mm | 886.30 mm |
| Cash burn (monthly) | 2.67 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 5.90 mm | n/a | n/a | n/a | n/a | n/a |
| Cash remaining | 880.40 mm | n/a | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 330.2 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2023
92.0% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 665 |
| Opened positions | 121 |
| Closed positions | 77 |
| Increased positions | 236 |
| Reduced positions | 211 |
| 13F shares | Current |
|---|---|
| Total value | 23.57 tn |
| Total shares | 68.30 mm |
| Total puts | 57.60 k |
| Total calls | 139.40 k |
| Total put/call ratio | 0.4 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 8.93 mm | $3.10 tn |
| BLK Blackrock | 8.03 mm | $2.78 tn |
| BK Bank Of New York Mellon | 3.57 mm | $1.24 tn |
| STT State Street | 3.29 mm | $1.14 tn |
| T. Rowe Price | 2.84 mm | $985.77 bn |
| APG Asset Management | 2.39 mm | $760.67 bn |
| BEN Franklin Resources | 2.29 mm | $792.80 bn |
| T. Rowe Price Investment Management | 1.72 mm | $596.43 bn |
| Geode Capital Management | 1.54 mm | $533.21 bn |
| FMR | 1.29 mm | $448.59 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 May 23 | Chad Winters | Common Stock | Option exercise | Dispose M | No | No | 339.51 | 872 | 296.05 k | 1,448.711 |
| 30 May 23 | Chad Winters | Common Stock | Option exercise | Acquire M | No | No | 143.43 | 872 | 125.07 k | 2,320.711 |
| 30 May 23 | Chad Winters | Stock Options Common Stock | Option exercise | Dispose M | No | No | 143.43 | 872 | 125.07 k | 456 |
| 30 May 23 | Charles Witherspoon | Common Stock | Sell | Dispose S | No | No | 343.05 | 1,000 | 343.05 k | 1,829.498 |
| 30 May 23 | Charles Witherspoon | Common Stock | Option exercise | Acquire M | No | No | 102.51 | 1,000 | 102.51 k | 2,829.498 |
| 30 May 23 | Charles Witherspoon | Stock Options Common Stock | Option exercise | Dispose M | No | No | 102.51 | 1,000 | 102.51 k | 1,548 |
| 9 May 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 365.458 | 500 | 182.73 k | 134,574.087 |
| 9 May 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 364.7645 | 4,133 | 1.51 mm | 135,074.087 |
| 9 May 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 363.9354 | 12,648 | 4.60 mm | 139,207.087 |
| 9 May 23 | Green Eric Mark | Common Stock | Sell | Dispose S | No | Yes | 362.9267 | 12,562 | 4.56 mm | 151,855.087 |
News
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
29 May 23
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today
11 May 23
Earnings Scheduled For April 27, 2023
27 Apr 23
West Pharmaceutical Servs Q1 Adjusted EPS $1.98 Beats $1.65 Estimate, Sales $716.60M Beat $693.82M Estimate
27 Apr 23
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 5 Years
20 Apr 23
Press releases
West to Participate in Upcoming Investor Conferences
24 May 23
West to Participate in Upcoming Investor Conference
4 May 23
West's Ready Pack™ containment solution with Corning® Valor® RTU Vials utilizing Stevanato Group's EZ-fill® technology recognized for Best Technologies Award at INTERPHEX
2 May 23
West Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend
27 Apr 23
West to Host First-Quarter 2023 Conference Call
13 Apr 23